Analytical Data
-
Gene name
CABP2
- Application
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9JLK4
-
Expression Region
Ala87~Arg221
-
Molecular Weight
16kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CABP2, or Calcium-binding protein 2, is a member of the calmodulin superfamily that plays a crucial role in neuronal signaling and calcium homeostasis. It is predominantly expressed in the retina and central nervous system, where it is believed to modulate the activity of ion channels and impact cellular calcium signaling pathways. Research into CABP2 has garnered interest due to its potential involvement in various neurological disorders and retinal diseases. The ability of CABP2 to bind calcium ions and interact with other proteins makes it an essential factor in synaptic transmission and neuronal excitability. Studies have shown that mutations in the CABP2 gene are linked to conditions such as autosomal dominant night blindness and other visual impairments. Moreover, the exploration of CABP2 and its functions has the potential to provide insights into the mechanisms underlying synaptic plasticity and neurodegeneration. As a result, the recombinant production of CABP2 protein is of significant interest, allowing researchers to investigate its structural properties, functional mechanisms, and interactions with other cellular components in detail. Understanding CABP2's role at the molecular level can pave the way for developing therapeutic strategies targeting related pathologies, highlighting the importance of this protein in both basic and clinical research.
